William W. Ericson, Director, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), bought 1,329,984 shares at $16.00 ($4.8M) on 2014-04-15, disclosed to the SEC on 2014-04-15.
Open-market purchase of $4.8M ADMS by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,029,984 | $0 | 0.0% |
| 2 | $16.00 | 3,146 | $50K | 1.0% |
| 3 | $16.00 | 6,043 | $97K | 2.0% |
| 4 | $16.00 | 25,661 | $411K | 8.6% |
| 5 | $16.00 | 265,150 | $4.2M | 88.4% |
| Total | $3.61 avg | 1,329,984 |
| $4.8M |
| 100% |
| Filing → |
| ADMS | BUY | 2016-09-16 | $2.1M | — | Filing → |
| ADMS | BUY | 2016-09-14 | $2.6M | — | Filing → |
| ADMS | BUY | 2016-09-09 | $1.9M | — | Filing → |